### Analysis of rs796052984: Dominant or Recessive?

The variant **rs796052984** is located in the **SCN1A** gene, which is associated with several neurological disorders, including **Dravet syndrome** and other forms of epilepsy. Based on the retrieved data and external knowledge, here is the analysis:

---

### 1. **Variant Identification**
- **rs Number**: [rs796052984](https://identifiers.org/dbsnp/rs796052984)
- **Gene**: SCN1A
- **Transcript**: Multiple transcripts are affected, including:
  - **NM_001165963.4:c.2722G>C** (p.Gly908Arg)
  - **NM_001165963.4:c.2722G>A** (p.Gly908Ser)
- **HGVS Notation**: 
  - For the C>G variant: `chr2:g.166038000C>G`
  - For the C>T variant: `chr2:g.166038000C>T`

---

### 2. **Disease Associations**
- **ClinVar Significance**:
  - The C>G variant is classified as **likely pathogenic (LP)**.
  - The C>T variant is classified as **uncertain significance (US)**.
- **Associated Conditions**:
  - **C>G Variant**: Likely associated with **epileptic encephalopathies**.
  - **C>T Variant**: Reported in conditions like **early infantile epileptic encephalopathy** but with uncertain significance.
- **Predictive Models**:
  - **SIFT**: 0.0 (deleterious)
  - **PolyPhen**: 0.999 (probably damaging for C>G; 0.998 for C>T)
  - **AlphaMissense**: 0.9997 (C>G) and 0.9872 (C>T), indicating high pathogenicity.

---

### 3. **Dominant or Recessive?**
The **SCN1A** gene is known to follow an **autosomal dominant inheritance pattern** for most of its associated disorders, including **Dravet syndrome** and **generalized epilepsy with febrile seizures plus (GEFS+).** 

- **Supporting Evidence**:
  - **Dravet Syndrome**: Caused by heterozygous mutations in SCN1A, which means a single copy of the mutated gene is sufficient to cause the disorder.
  - **Functional Impact**: Variants like **p.Gly908Arg** and **p.Gly908Ser** are predicted to severely affect the function of the sodium channel encoded by SCN1A, consistent with a dominant effect.

Thus, **rs796052984 is most likely a dominant variant**.

---

### 4. **Additional Information**
- **Population Frequency**:
  - The C>T variant has a very low allele frequency in gnomAD (7.52e-06), consistent with a rare, potentially pathogenic variant.
- **TogoVar Link**: [TogoVar rs796052984](https://togovar.org/variant/2-166038000-C-T)

---

### Conclusion
The variant **rs796052984** is associated with **autosomal dominant inheritance**, particularly in the context of SCN1A-related disorders like **Dravet syndrome**. However, the exact clinical significance may vary depending on the specific nucleotide change (C>G or C>T) and the associated condition.

---

### 日本語での説明
#### rs796052984: 優性または劣性か？
**rs796052984**は、神経疾患（特に**Dravet症候群**やてんかん）に関連する**SCN1A**遺伝子に位置しています。この変異の遺伝形式について以下の通り説明します。

---

### 1. **変異の特定**
- **rs番号**: [rs796052984](https://identifiers.org/dbsnp/rs796052984)
- **遺伝子**: SCN1A
- **転写産物**: 
  - **NM_001165963.4:c.2722G>C** (p.Gly908Arg)
  - **NM_001165963.4:c.2722G>A** (p.Gly908Ser)
- **HGVS表記**: 
  - C>G変異: `chr2:g.166038000C>G`
  - C>T変異: `chr2:g.166038000C>T`

---

### 2. **疾患との関連性**
- **ClinVarの意義**:
  - C>G変異: **病的意義が高い (likely pathogenic)**。
  - C>T変異: **意義不明 (uncertain significance)**。
- **関連疾患**:
  - **C>G変異**: **てんかん性脳症**に関連。
  - **C>T変異**: **早期乳児てんかん性脳症**などで報告されているが、意義は不明。
- **予測モデル**:
  - **SIFT**: 0.0（有害）
  - **PolyPhen**: 0.999（C>Gの場合、ほぼ確実に有害）
  - **AlphaMissense**: 0.9997（C>G）、0.9872（C>T）

---

### 3. **優性または劣性か？**
**SCN1A**遺伝子は、**常染色体優性遺伝**の形式で疾患を引き起こすことが知られています（例: **Dravet症候群**、**GEFS+**）。

- **根拠**:
  - **Dravet症候群**: SCN1Aのヘテロ接合型変異（片方の遺伝子コピーの変異）が疾患を引き起こす。
  - **機能的影響**: **p.Gly908Arg**や**p.Gly908Ser**のような変異は、SCN1Aがコードするナトリウムチャネルの機能に重大な影響を与えると予測されており、優性効果と一致。

したがって、**rs796052984は優性変異である可能性が高い**です。

---

### 4. **追加情報**
- **集団頻度**:
  - C>T変異はgnomADで非常に低い頻度（7.52e-06）であり、稀で病的である可能性が示唆されます。
- **TogoVarリンク**: [TogoVar rs796052984](https://togovar.org/variant/2-166038000-C-T)

---

### 結論
**rs796052984**は、特に**Dravet症候群**などのSCN1A関連疾患において、**常染色体優性遺伝**に関連する変異と考えられます。ただし、特定の塩基変化（C>GまたはC>T）や関連疾患によって臨床的意義が異なる場合があります。